These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27109766)

  • 1. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating.
    Kim SM; Park KS; Lih E; Hong YJ; Kang JH; Kim IH; Jeong MH; Joung YK; Han DK
    Acta Biomater; 2016 Jul; 38():143-52. PubMed ID: 27109766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
    Bedair TM; Kang SN; Joung YK; Han DK
    J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
    Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
    Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
    J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented re-endothelialization and anti-inflammation of coronary drug-eluting stent by abluminal coating with magnesium hydroxide.
    Jeong DW; Park W; Bedair TM; Kang EY; Kim IH; Park DS; Sim DS; Hong YJ; Koh WG; Jeong MH; Han DK
    Biomater Sci; 2019 May; 7(6):2499-2510. PubMed ID: 30957801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus coating on heparinized stents prevents restenosis and thrombosis.
    Bae IH; Lim KS; Park DS; Shim JW; Lee SY; Jang EJ; Park JK; Kim JH; Jeong MH
    J Biomater Appl; 2017 May; 31(10):1337-1345. PubMed ID: 28436251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
    Huang Y; Venkatraman SS; Boey FY; Umashankar PR; Mohanty M; Arumugam S
    J Interv Cardiol; 2009 Oct; 22(5):466-78. PubMed ID: 19627432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model.
    Bae IH; Jeong MH; Kim JH; Park YH; Lim KS; Park DS; Shim JW; Kim JH; Ahn Y; Hong YJ; Sim DS
    Korean Circ J; 2017 Jan; 47(1):123-131. PubMed ID: 28154600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
    Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
    J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.